BioCardia (BCDA) Stock Insights
BCDA$0.93-0.02 -2.26%
$14.02M
Market Cap
-1.21
P/E
—
Forward P/E
51
Score
BioCardia (BCDA) Stock Insights
BCDA price $0.93 -0.02 -2.26%
- Ticker
- BCDA
- Price
- $0.93
- Change
- -0.02 -2.26%
- Market cap ?
- $14.02M
- P/E ?
- -1.21
- Dividend yield ?
- 0.00%
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 51
- Value
- 58
- Quality
- 46
- Growth
- 50
Stocklytics score rationale: value 58, quality 46, growth 50.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 576000 | 479000 | 625000 | 710000 | 145000 | 1015000 | 1352000 | 477000 | 58000 | 0 |
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program…
Insights · Dividends · Forecast · Financials · Learn